全文获取类型
收费全文 | 990篇 |
免费 | 60篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 30篇 |
妇产科学 | 22篇 |
基础医学 | 112篇 |
口腔科学 | 16篇 |
临床医学 | 172篇 |
内科学 | 237篇 |
皮肤病学 | 3篇 |
神经病学 | 72篇 |
特种医学 | 11篇 |
外科学 | 113篇 |
综合类 | 7篇 |
一般理论 | 2篇 |
预防医学 | 76篇 |
眼科学 | 32篇 |
药学 | 90篇 |
中国医学 | 7篇 |
肿瘤学 | 46篇 |
出版年
2023年 | 13篇 |
2022年 | 25篇 |
2021年 | 55篇 |
2020年 | 32篇 |
2019年 | 35篇 |
2018年 | 33篇 |
2017年 | 24篇 |
2016年 | 33篇 |
2015年 | 40篇 |
2014年 | 34篇 |
2013年 | 57篇 |
2012年 | 82篇 |
2011年 | 86篇 |
2010年 | 37篇 |
2009年 | 39篇 |
2008年 | 73篇 |
2007年 | 73篇 |
2006年 | 49篇 |
2005年 | 51篇 |
2004年 | 34篇 |
2003年 | 26篇 |
2002年 | 35篇 |
2001年 | 14篇 |
2000年 | 8篇 |
1999年 | 3篇 |
1998年 | 9篇 |
1997年 | 9篇 |
1996年 | 3篇 |
1995年 | 3篇 |
1994年 | 5篇 |
1993年 | 4篇 |
1992年 | 6篇 |
1991年 | 4篇 |
1990年 | 3篇 |
1988年 | 2篇 |
1987年 | 1篇 |
1986年 | 2篇 |
1984年 | 1篇 |
1982年 | 7篇 |
1981年 | 2篇 |
1980年 | 1篇 |
排序方式: 共有1053条查询结果,搜索用时 15 毫秒
81.
82.
83.
Association study of novel human serotonin 5-HT(1B) polymorphisms with alcohol dependence in Taiwanese Han. 总被引:6,自引:0,他引:6
Hsiao Fang Sunny Sun Yuh Terng Chang Cathy Shen-Jang Fann Ching Jui Chang Yi Hsin Chen Yun Pung Hsu Wu Yang Yu Andrew Tai-Ann Cheng 《Neuropsychopharmacology》2002,51(11):896-901
BACKGROUND: Abnormal serotonergic pathways are implicated in numerous neuropsychiatric disorders, such as depression, anxiety, migraine, substance abuse, and alcoholism. The human serotonin receptor 1B, encoded by the HTR1B gene, is a presynaptic serotonin autoreceptor that plays a role in regulating serotonin synthesis and release. Because the linkage of antisocial alcoholism to the HTR1B gene was recently reported in two populations, it was of interest to identify genetic variants at the HTR1B locus and study their association with alcoholism in the Taiwanese Han population. METHODS: We sequenced DNA from Taiwanese Han to screen for genetic variation in the coding, promoter, and partial 3' untranslated regions of the HTR1B locus of 158 alcohol-dependent cases with withdrawal symptoms and 149 control subjects, who either never drank or drank only occasionally and in low quantities. RESULTS: Seven variants were identified. Positive associations were found between variant A-161T and alcohol dependence at both the allelic and genotypic level. In addition, an expression study showed that the A-161T variant affected reporter gene activity. CONCLUSIONS: Our results support an association between HTR1B and alcohol dependence. The HTR1B A-161T polymorphism may be valuable both as a functional and as an anonymous genetic marker for HTR1B. 相似文献
84.
85.
86.
87.
和化妆品中所含的铅、汞等违禁成分不同,保养品中所含的防腐剂之类的成分往往被合理添加,这些成分的危害短期内难以发现,但长期使用就成了问题肌肤的源头。 相似文献
88.
89.
Rohatagi S Chapel S Kirkesseli S Newman S Zhang J Paccaly D Randall L Wray H Wellington S Shah B Jensen BK 《American journal of therapeutics》2004,11(2):103-113
A pharmacoscintigraphic study was conducted to compare the dose deposition of HMR 1031 from the existing nebulizer formulation and the new Ultrahaler device to help determine the doses for future phase 2 trials. This was a single-dose, open-label, randomized, two-way crossover study in which HMR 1031 (3 mg) was delivered by the Ultrahaler and the Pari LC Star nebulizer to 12 healthy male subjects. For both treatments, the formulations were radiolabeled with technetium-99m pertechnetate such that a maximum of 10 MBq was delivered on each study day. Scintigraphic images were acquired immediately after dosing to estimate the percentage of the dose delivered to the lungs and oropharynx. Serial plasma samples were collected up to 12 hours post-dose on each occasion and analyzed for HMR 1031 by a LC/MS/MS method with a lower limit of quantitation of 10 pg/mL (0.01 ng/mL). Pharmacokinetic parameters were calculated for HMR 1031 using noncompartmental methods. No serious adverse events were reported. The systemic absorption of HMR 1031 following inhalation administration was relatively rapid, with median T(max) values of 0.5 hours and 1.0 hours post-dose after administration via Ultrahaler and nebulizer, respectively. The mean plasma AUC(0-12) (Ultrahaler, 15.8 ng*h/mL; nebulizer, 11.1 ng*h/mL) and C(max) (Ultrahaler, 4.96 ng/mL; nebulizer, 2.28 ng/mL) values were approximately 42% and 118% higher for the Ultrahaler compared with the nebulizer. The mean terminal half-life of HMR 1031 was similar after administration from both devices (2.91 and 3.18 hours). Based on the scintigraphic data, the lung deposition of HMR 1031 after administration by Ultrahaler (24.6% of the administered dose) was approximately 37% higher compared with the lung deposition from the nebulizer (18.0% of the administered dose). This observation was in agreement with the relative difference in the plasma AUC values achieved after administration of the two formulations. The in vivo results based on the scintigraphic data were also comparable with those from in vitro studies for the Ultrahaler. Based on the ratio of the dose delivered by both the formulations, the required doses for the future Ultrahaler formulation can be predicted. 相似文献
90.